Dose-dense therapy improves survival in aggressive non-Hodgkin"s lymphoma.

Michael A Fridrik; Hubert Hausmaninger; Alois Lang; Johannes Drach; Otto Krieger; Dietmar Geissler; Gerhard Michlmayr; Ernst Ulsperger; Andreas Chott; Wilhelm Oberaigner; Richard Greil

doi:10.1007/s00277-009-0811-x

Dose-dense therapy improves survival in aggressive non-Hodgkin"s lymphoma.

Michael A Fridrik, Hubert Hausmaninger, Alois Lang, Johannes Drach, Otto Krieger, Dietmar Geissler, Gerhard Michlmayr, Ernst Ulsperger, Andreas Chott, Wilhelm Oberaigner, Richard Greil (Last author)

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

4 Citations (Web of Science)

Original language	English
Pages (from-to)	273-282
Journal	ANNALS OF HEMATOLOGY
Volume	89
Issue number	3
DOIs	https://doi.org/10.1007/s00277-009-0811-x
Publication status	Published - 2010

Keywords

STEM-CELL SUPPORT
ELDERLY-PATIENTS
MULTICENTER TRIAL
CHOP CHEMOTHERAPY
RANDOMIZED TRIAL
RITUXIMAB
INTERMEDIATE
RADIOTHERAPY
GRADE
ACVBP

Access to Document

10.1007/s00277-009-0811-x

Cite this

Fridrik, M. A., Hausmaninger, H., Lang, A., Drach, J., Krieger, O., Geissler, D., Michlmayr, G., Ulsperger, E., Chott, A., Oberaigner, W., & Greil, R. (2010). Dose-dense therapy improves survival in aggressive non-Hodgkin"s lymphoma. ANNALS OF HEMATOLOGY , 89(3), 273-282. https://doi.org/10.1007/s00277-009-0811-x

Fridrik, Michael A ; Hausmaninger, Hubert ; Lang, Alois et al. / Dose-dense therapy improves survival in aggressive non-Hodgkin"s lymphoma. In: ANNALS OF HEMATOLOGY 2010 ; Vol. 89, No. 3. pp. 273-282.

@article{195d9aedae56411e9c78961395513027,

title = "Dose-dense therapy improves survival in aggressive non-Hodgkin{"}s lymphoma.",

keywords = "STEM-CELL SUPPORT, ELDERLY-PATIENTS, MULTICENTER TRIAL, CHOP CHEMOTHERAPY, RANDOMIZED TRIAL, RITUXIMAB, INTERMEDIATE, RADIOTHERAPY, GRADE, ACVBP",

author = "Fridrik, {Michael A} and Hubert Hausmaninger and Alois Lang and Johannes Drach and Otto Krieger and Dietmar Geissler and Gerhard Michlmayr and Ernst Ulsperger and Andreas Chott and Wilhelm Oberaigner and Richard Greil",

note = "Department Medicine, University Salzburg, Salzburg, Austria",

year = "2010",

doi = "10.1007/s00277-009-0811-x",

language = "English",

volume = "89",

pages = "273--282",

journal = "ANNALS OF HEMATOLOGY ",

issn = "0939-5555",

number = "3",

}

Fridrik, MA, Hausmaninger, H, Lang, A, Drach, J, Krieger, O, Geissler, D, Michlmayr, G, Ulsperger, E, Chott, A, Oberaigner, W & Greil, R 2010, 'Dose-dense therapy improves survival in aggressive non-Hodgkin"s lymphoma.', ANNALS OF HEMATOLOGY , vol. 89, no. 3, pp. 273-282. https://doi.org/10.1007/s00277-009-0811-x

Dose-dense therapy improves survival in aggressive non-Hodgkin"s lymphoma. / Fridrik, Michael A; Hausmaninger, Hubert; Lang, Alois et al.
In: ANNALS OF HEMATOLOGY , Vol. 89, No. 3, 2010, p. 273-282.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Dose-dense therapy improves survival in aggressive non-Hodgkin"s lymphoma.

AU - Fridrik, Michael A

AU - Hausmaninger, Hubert

AU - Lang, Alois

AU - Drach, Johannes

AU - Krieger, Otto

AU - Geissler, Dietmar

AU - Michlmayr, Gerhard

AU - Ulsperger, Ernst

AU - Chott, Andreas

AU - Oberaigner, Wilhelm

AU - Greil, Richard

N1 - Department Medicine, University Salzburg, Salzburg, Austria

PY - 2010

Y1 - 2010

KW - STEM-CELL SUPPORT

KW - ELDERLY-PATIENTS

KW - MULTICENTER TRIAL

KW - CHOP CHEMOTHERAPY

KW - RANDOMIZED TRIAL

KW - RITUXIMAB

KW - INTERMEDIATE

KW - RADIOTHERAPY

KW - GRADE

KW - ACVBP

U2 - 10.1007/s00277-009-0811-x

DO - 10.1007/s00277-009-0811-x

M3 - Original Article

C2 - 19693500

SN - 0939-5555

VL - 89

SP - 273

EP - 282

JO - ANNALS OF HEMATOLOGY

JF - ANNALS OF HEMATOLOGY

IS - 3

ER -

Fridrik MA, Hausmaninger H, Lang A, Drach J, Krieger O, Geissler D et al. Dose-dense therapy improves survival in aggressive non-Hodgkin"s lymphoma. ANNALS OF HEMATOLOGY . 2010;89(3):273-282. doi: 10.1007/s00277-009-0811-x